CD8A and melanoma: OVA-transfected melanoma cell line transplantation, followed by transfer of OVA-sensitive T cells (OT), enables evaluation of the effect of antigen recognition by CD8+ T cells on tumor eradication but yields a rapid expansion of exogenous tumor mass with very high antigen content.